Abstract:Patient-reported outcomes (PROs) play an increasingly important role in clinical practice and research. Modern psychometric methods such as item response theory (IRT) enable the creation of item banks that support fixed-length forms as well as computerized adaptive testing (CAT), often resulting in improved measurement precision and responsiveness. Here we describe and discuss the case for developing an international core set of PROs building from the US PROMIS® network.PROMIS is a U.S.-based cooperative group of research sites and centers of excellence convened to develop and standardize PRO measures across studies and settings. If extended to a global collaboration, PROMIS has the potential to transform PRO measurement by creating a shared, unifying terminology and metric for reporting of common symptoms and functional life domains. Extending a common set of standardized PRO measures to the international community offers great potential for improving patient-centered research, clinical trials reporting, population monitoring, and health care worldwide. Benefits of such standardization include the possibility of: international syntheses (such as meta-analyses) of research findings; international population monitoring and policy development; health services administrators and planners access to relevant information on the populations they serve; better assessment and monitoring of patients by providers; and improved shared decision making.The goal of the current PROMIS International initiative is to ensure that item banks are translated and culturally adapted for use in adults and children in as many countries as possible. The process includes 3 key steps: translation/cultural adaptation, calibration, and validation. A universal translation, an approach focusing on commonalities, rather than differences across versions developed in regions or countries speaking the same language, is proposed to ensure conceptual equivalence for all items. International item calibration using nationally representative samples of adults and children within countries is essential to demonstrate that all items possess expected strong measurement properties. Finally, it is important to demonstrate that the PROMIS measures are valid, reliable and responsive to change when used in an international context.IRT item banking will allow for tailoring within countries and facilitate growth and evolution of PROs through contributions from the international measurement community. A number of opportunities and challenges of international development of PROs item banks are discussed.

PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability

Improving care for rare genetic neurodevelopmental disorders: a systematic review and critical appraisal of clinical practice guidelines using AGREE II

Measuring what matters: Why and how to include patient reported outcomes in clinical care and research on inborn errors of metabolism

Improving the care of children with GENetic Rare disease: Observational Cohort study (GenROC): a study protocol

Improving the care of children with GENetic Rare disease: Observational Cohort study (GenROC)--a study protocol

Patient-reported outcomes and quality of life in PMM2-CDG

Patient and family engagement in the development of core outcome sets for two rare chronic diseases in children

Development of the pediatric narcolepsy patient-reported outcomes scale (PN-PROs)

Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures

Bridging the clinical-research gap: Harnessing an electronic data capture, integration, and visualization platform to systematically assess prospective patient-reported outcomes in mitochondrial medicine

Lessons learned from the RE(ACT) conference on medical devices for rare diseases

Psychometric properties of the Pediatric Evaluation of Disability Inventory – Patient Reported Outcome: A cognitively accessible measure of functional performance

Development of a novel Patient-Reported Outcome Measure (PROM) for adults with an Inherited Cardiac Condition (ICC)

Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases

Common data elements to standardize genomics studies in cerebral palsy

Barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries: a scoping review protocol

Gathering the Stakeholder's Perspective: Experiences and Opportunities in Rare Genetic Disease Research

Are disease-specific patient-reported outcomes measures (PROMs) used in cardiogenetics? A systematic review

A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE study

The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative

Patient preferences in genetic newborn screening for rare diseases: study protocol